Sorafenib in Thyroid Cancer Patients: Learning From Toxicity In Reply

被引：0
|
作者：
Cabanillas, Maria E. [1 ]
Dadu, Ramona [1 ]
Lai, Stephen Y. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
来源：
ONCOLOGIST | 2014年 / 19卷 / 08期
关键词：
D O I：
10.1634/theoncologist.2014-0186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E4 / E4
页数：1
相关论文
共 50 条
  • [41] Treatment with sorafenib in advanced thyroid cancer - a case report
    Krajewska, Jolanta
    Olczyk, Tomasz
    Roskosz, Jozef
    Paliczk-Cieslik, Ewa
    Kukulska, Aleksandra
    Smietana, Anetta
    Kaczmarek-Borowska, Bozenna
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2010, 61 (05) : 492 - 496
  • [42] Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
    Kloos, Richard T.
    Ringel, Matthew D.
    Knopp, Michael V.
    Hall, Nathan C.
    King, Mark
    Stevens, Robert
    Liang, Jiachao
    Wakely, Paul E., Jr.
    Vasko, Vasyl V.
    Saji, Motoyasu
    Rittenberry, Jennifer
    Wei, Lai
    Arbogast, Daria
    Collamore, Minden
    Wright, John J.
    Grever, Michael
    Shah, Manisha H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1675 - 1684
  • [43] pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer
    Yarchoan, Mark
    Ma, Changqing
    Troxel, Andrea B.
    Stopenski, Stephen J.
    Tang, Waixing
    Cohen, Aaron B.
    Pappas-Paxinos, Marina
    Johnson, Burles A., III
    Chen, Emerson Y.
    Feldman, Michael D.
    Brose, Marcia S.
    HORMONES & CANCER, 2016, 7 (03): : 188 - 195
  • [44] Sorafenib in thyroid cancer-a retrospective case series
    Gamerith, Gabriele
    Pircher, Andreas
    Amann, Arno
    Cima, Katharina
    Gasser, Klaus
    Lenzhofer, Markus
    Lind, Peter
    Bareck, Evelyne
    Woell, Ewald
    Hilbe, Wolfgang
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2012, 5 (03) : 246 - 249
  • [45] COST AND EFFECTIVENESS OF THE USE OF SORAFENIB IN DIFFERENTIATED THYROID CANCER
    Carrasquilla-Sotomayor, M.
    Alvis-Zakzuk, N. J.
    Gomez de la Rosa, F.
    Alvis Zakzuk, J.
    Marrugo Figueroa, R. D.
    Miranda Machado, P.
    Alvis Guzman, N.
    Herran Diazgranado, S. E.
    VALUE IN HEALTH, 2017, 20 (09) : A876 - A876
  • [46] Response to sorafenib treatment in advanced metastatic thyroid cancer
    Pitoia, Fabian
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (01) : 37 - 41
  • [47] Sorafenib in radioactive iodine-refractory thyroid cancer
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (06): : 453 - 453
  • [48] Lymph Node Biopsy in Patients With Papillary Thyroid Cancer Reply
    Cabrera, Raquel N.
    Mattiolli, Aline
    Etchebehere, Elba C. S. C.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2017, 143 (04) : 429 - 430
  • [49] Financial toxicity in thyroid cancer: An analysis from the North American Thyroid Cancer Survivorship study.
    De Souza, Jonas A.
    Grogan, Raymon
    Aschebrook-Kilfoy, Brisa
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [50] Financial Toxicity in Thyroid Cancer-An Analysis From the North American Thyroid Cancer Survivorship Study
    de Souza, J. A.
    Grogan, R.
    Aschebrook-Kilfoy, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 960 - 960
12345